Regeneron agrees to $270m extension to supply Ebola medicine in US
The arrangement builds on a partnership with the Biomedical Advanced Research and Development Authority (BARDA) established in 2020. BARDA is part of the Administration for Strategic Preparedness and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.